| Fund ID | 805-2999119990 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 9% |
| Fund | Type | Gross assets |
|---|---|---|
| Aegis Special Situations Fund LLC - Series Medtech II | Private Equity | $19.5M |
| Aegis Special Situations Fund LLC - Series Medtech V | Private Equity | $14.8M |
| Aegis Special Situations Fund LLC - Series Aerospace III | Private Equity | $13.7M |
Aegis Special Situations Qp Fund LLC - Series Plant Protein 1 reports $1.4 million in gross assets, among the top 93% of private funds by size.
The stated minimum investment is $100,000.
Aegis Special Situations Qp Fund LLC - Series Plant Protein 1 is managed by Aegis Capital Corp.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.